The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignanciesElise R. A. Pennings, Marie José Kersten, Ulrich Jaeger et al.|HemaSphere|2026Cited by 2
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Jacquelyn Awigena-Cook, Carmen Sanges et al.|Cytotherapy|2025Cited by 0